✦ LIBER ✦

Oseltamivir–zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses

✍ Scribed by Pizzorno, Andrés; Abed, Yacine; Rhéaume, Chantal; Boivin, Guy

Book ID: 121921617
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 800 KB
Volume: 105
Category: Article
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2014.02.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical effectiveness of neuraminidase

Clinical effectiveness of neuraminidase inhibitors—oseltamivir, zanamivir, laninamivir, and peramivir—for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010–2011 influenza season in Japan

✍ Shobugawa, Yugo; Saito, Reiko; Sato, Isamu; Kawashima, Takashi; Dapat, Clyde; Da 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 205 KB

Evolution of Oseltamivir Resistance Muta

Evolution of Oseltamivir Resistance Mutations in Influenza A(H1N1) and A(H3N2) Viruses during Selection in Experimentally Infected Mice

✍ Pizzorno, A.; Abed, Y.; Plante, P.-L.; Carbonneau, J.; Baz, M.; Hamelin, M.-E.; 📂 Article 📅 2014 🏛 American Society for Microbiology 🌐 English ⚖ 858 KB

In vitro passaging of a pandemic H1N1/09

In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir

✍ McKimm-Breschkin, J. L.; Rootes, C.; Mohr, P. G.; Barrett, S.; Streltsov, V. A. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 690 KB